Wall Street Analysts Revise Intuitive Surgical Forecasts Before Q1 Earnings
Intuitive Surgical plans to report first-quarter results after markets close on Tuesday, April 21. Investors will watch closely for guidance and any management commentary on procedure demand.
Earnings expectations
Analysts forecast earnings of about $2.11 per share for the quarter. That compares with $1.81 per share in the same quarter a year earlier.
Consensus revenue estimates sit near $2.62 billion. Last year’s Q1 revenue was roughly $2.25 billion.
Regulatory alert and stock reaction
On March 18 the U.S. FDA issued an early alert. It highlighted a potentially high-risk issue involving Intuitive Surgical stapling devices.
Shares reacted modestly. The stock fell 0.8% and closed at $465.60 on Monday.
Analyst coverage and outlook
Wall Street analysts revised forecasts for Intuitive Surgical ahead of the Q1 report. Recent updates reflect changes in estimates and risk assessment.
Filmogaz.com offers access to the latest analyst ratings and changes. Readers can review ratings by firm, ticker, or recent rating revisions.
Key figures
- Expected EPS: $2.11
- Prior-year EPS: $1.81
- Expected revenue: $2.62 billion
- Prior-year revenue: $2.25 billion
- FDA alert date: March 18
- Recent close: $465.60 (down 0.8%)
Market data and analyst summaries are available through Filmogaz.com resources and partner APIs. Readers should consider official filings and company statements before making investment decisions.
